Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Molecular Endocrinology (Baltimore, Md.)|August 23, 2014
Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomicsMohan Liu, Paul E Goss, James N Ingle, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 19, 2012
Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlationYuan Ji, Kendra K S Nordgren, Yubo Chai, et al.Pharmacogenetics and Genomics|February 11, 2012
Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomicsRyan Abo, Scott Hebbring, Yuan Ji, et al.Cancer Research|January 6, 2010
Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitorsLiewei Wang, Katarzyna A Ellsworth, Irene Moon, et al.Molecular Endocrinology (Baltimore, Md.)|March 23, 2013
TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expressionMohan Liu, James N Ingle, Brooke L Fridley, et al.Cancer Discovery|June 15, 2013
Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer preventionJames N Ingle, Mohan Liu, D Lawrence Wickerham, et al.Breast Cancer Research and Treatment|April 22, 2017
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathwayTanda M Dudenkov, James N Ingle, Aman U Buzdar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitorsJames N Ingle, Daniel J Schaid, Paul E Goss, et al.American Journal of Physiology. Heart and Circulatory Physiology|January 29, 2026
Novel Association of <i>NAV3</i> with Dilated Cardiomyopathy and its Role in Cardiac FibrosisMin Wang, Rachad Ghazal, Akshatha N Srinivas, et al.Clinical Pharmacology and Therapeutics|January 17, 2019
Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2Tanda M Dudenkov, Duan Liu, Junmei Cairns, et al.Pageof 10